Sofinnova Partners

EnginZyme develops cell-free biomanufacturing technology that uses immobilized enzymes to make chemicals and ingredients through scalable industrial processes.

HighLife Medical develops a transcatheter mitral-valve replacement system designed to treat patients with severe mitral regurgitation without open-heart surgery.

Mironid develops small-molecule medicines for inherited kidney disease, with a lead programme targeting autosomal dominant polycystic kidney disease.

Bionyra Pharma develops biologic therapies for severe immunological and inflammatory diseases.

Builds AI architecture fusing biological data modalities to accelerate pharma and biotech drug development

Develops inobrodib, a first-in-class oral p300/CBP inhibitor for relapsed or refractory multiple myeloma

Develops in vivo engineered monocyte immunotherapy to treat solid tumours in preclinical stage

Neurent Medical develops NEUROMARK, a minimally invasive radiofrequency treatment for chronic rhinitis.

BrightHeart develops AI software for prenatal ultrasound and fetal-heart screening.